Tumor-on-a-chip method reveals timing as a factor in glioblastoma immunotherapy. A joint research team led by professors Sungsu Park of Sungkyunkwan University and Sun-Ha Paek of Seoul National University College of Medicine has demonstrated for the first time that the sequence in which immune cells interact with cancer cells can critically influence the therapeutic response in glioblastoma.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: A joint research team led by professors Sungsu Park of Sungkyunkwan University and Sun-Ha Paek of Seoul National University College of Medicine has demonstrated for the first time that the sequence in which immune cells interact with cancer cells can critically influence the therapeutic response in glioblastoma.
- Ponto de atenção: tumor.
- Ponto de atenção: chip.
- Ponto de atenção: method.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
